查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000736

外科手套市場：按類型、材質、含粉/不含粉、銷售管道、應用和最終用戶分類－2026-2032年全球市場預測

Surgical Gloves Market by Type, Material, Powder, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科手套市場價值將達到 26 億美元，到 2026 年將成長到 27.5 億美元，到 2032 年將達到 39.6 億美元，複合年成長率為 6.20%。

主要市場統計數據
基準年 2025 26億美元
預計年份：2026年 27.5億美元
預測年份 2032 39.6億美元
複合年成長率 (%) 6.20%

外科手套產業處於臨床安全、供應鏈複雜性和不斷發展的材料科學的交匯點，已成為醫療機構和採購團隊的焦點。近年來，對高性能防護屏障的需求不斷成長，加之監管力度加大和製造地的轉移，相關人員對品質、可追溯性和成本效益的關注度顯著提高。本分析整合了影響採購決策和營運風險的當前因素，重點在於材料選擇、臨床應用和分銷方式如何從整體上影響臨床結果和醫療預算。

在所有醫療機構中，採購經理必須平衡感染預防的需求與產品舒適度、臨床醫師偏好等實際因素。同時，製造商面臨創新聚合物配方、減少環境影響以及確保批次間品質一致性的壓力。因此，籌資策略、驗證通訊協定和庫存管理實務的變革對於醫療機構的韌性至關重要。本實施方案概述了後續章節的框架，重點介紹決策者可用的策略工具，以在不影響臨床療效的前提下，最佳化安全性、供應連續性和總體擁有成本 (TCO)。

材料方面的突破、更嚴格的法規、不斷發展的採購管道以及臨床實踐的變化，正在全面改變供應商和買家的策略。

外科手套市場格局正經歷著一場變革性的轉變，其促進因素包括供應商動態、產品系列以及臨床實踐的改變。首先，材料創新正在加速發展。新型聚合物和改良的丁腈配方拓展了觸感靈敏度和減少過敏原的選擇範圍，迫使臨床醫生和採購團隊重新評估傳統的偏好。其次，更嚴格的法規和品質要求促使人們更加關注無菌性、細胞毒性以及生產可追溯性。因此，能夠證明自身符合相關法規的供應商變得越來越有價值。

評估美國關稅政策調整對進口的影響（截至 2025 年）對供應鏈、採購和購買的累積影響。

影響美國貿易和關稅政策至2025年的政策變化，正為外科手套價值鏈增添新的複雜性，其累積效應從原料採購到醫院採購，層層遞進。儘管官方關稅稅率和具體分類隨時間而變化，但其整體影響卻始終如一。具體而言，不斷上漲的進口成本引發了關於製造業回流、供應商選擇標準調整的討論，並促使買家重新評估庫存策略，以降低跨境成本波動帶來的風險。因此，製造商和經銷商正在探索調整合約價格、對沖採購管道風險以及實現供應商多元化等方案，以維持利潤率和供應穩定性。

透過綜合細分分析，揭示材料選擇、臨床環境、產品類型、粉末偏好和分銷管道如何影響採購決策。

透過全面而非孤立地考慮產品屬性、終端用戶環境和分銷模式，可以獲得有意義的市場區隔洞察。乳膠、丁腈橡膠、聚異戊二烯和乙烯基等不同材料各自具有獨特的價值提案。乳膠仍具備一些臨床醫生所青睞的傳統性能特徵，例如彈性和貼合性。丁腈橡膠具有廣泛的耐化學性和低致敏性。聚異戊二烯不含天然橡膠蛋白，觸感與乳膠相似。乙烯基仍然是低風險、短時任務的經濟之選。這些材料特性與臨床應用的需求相互作用。例如，心血管外科、普通外科、整形外科以及整形和重組外科等外科專科對觸覺靈敏度、抗穿刺性和無菌性的要求各不相同。

影響美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和採購現狀，以及這些趨勢和現狀如何影響採購、合規性和供應可靠性。

區域趨勢正顯著影響著美洲、歐洲、中東和非洲以及亞太市場的供應韌性、監管預期和採購行為。在美洲，籌資策略往往著重於加強與那些優先考慮物流可靠性和遵守當地法規結構的供應商的關係。同時，買家也考慮近岸外包，以減少跨洋運輸中斷的影響。相較之下，在歐洲、中東和非洲，不同的監管和報銷環境，以及認證協調和各國特定的公共採購規則，都對供應商的准入和合約模式產生了重大影響。

企業採取的競爭性和策略性行動，例如投資於無菌生產能力、可追溯性和服務差異化，決定了長期供應商的選擇。

產業重組、垂直整合和技術驅動的差異化正在重塑製造商、契約製造製造商和仲介業者之間的競爭格局。領先的製造商正投資於品管系統、無菌生產線和可追溯性技術，以滿足日益成長的臨床和監管要求；而契約製造和自有品牌合作夥伴則在靈活性和成本最佳化方面展開競爭。經銷商和直銷機構則透過提供諸如滅菌驗證支援、臨床人員產品培訓計畫以及數據驅動的庫存最佳化工具等綜合服務來提升自身價值提案，從而降低缺貨和產品過時的風險。

為增強韌性和客戶價值，可採取的策略重點包括多元化採購、以臨床為中心的創新以及以服務為導向的商業模式。

產業領導企業應推動一系列合作舉措，以增強供應鏈韌性、提升產品質量，並使商業性提案適應不斷變化的臨床需求。首先，應投資多元化的籌資策略，結合區域生產能力、檢驗的二級供應商和庫存緩衝，以降低貿易政策波動和物流中斷帶來的風險。同時，他們必須加快採用能夠解決過敏原問題並提供適用於高級外科手術的觸感性能的材料和產品特性，並確保滅菌和品管系統符合日益嚴格的監管要求。

採用混合研究途徑，結合一手訪談、營運評估、監管審查和情境分析，以支持可操作的策略見解。

本研究採用混合方法，結合關鍵相關人員訪談、營運審計、監管文件審查和供應鏈圖譜分析，以全面了解當前趨勢。主要訪談對象包括採購經理、臨床終端使用者、生產營運經理和分銷合作夥伴，從​​而獲得有關選擇因素、風險接受度和合約行為的定性見解。作為這些訪談的補充，營運審計和生產評估提供了有關生產能力、滅菌流程和品管系統穩健性的客觀指標。

策略挑戰的整合，重點闡述了整合採購、品質保證和臨床協作如何增強韌性和競爭優勢。

總之，材料創新、監管細則的完善、分銷模式的轉變以及政策主導的供應鏈壓力正在重塑外科手套的市場格局。這些因素共同迫使製造商、經銷商和醫療採購商採取更精細的採購、產品差異化和服務策略。積極投資於多元化供應鏈、無菌生產能力以及以臨床醫生為中心的產品研發的企業，將更有能力應對關稅相關的成本壓力和不斷變化的臨床需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科手套市場：按類型分類

  • 非無菌
  • 已滅菌

第9章 外科手套市場：依材料分類

  • 乳膠
  • 丁腈橡膠
  • 聚異戊二烯
  • 乙烯基塑膠

第10章：按粉末類型分類的外科手套市場

  • 無粉
  • 粉狀

第11章 外科手套市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上零售
    • B2B平台
    • B2C平台

第12章 外科手套市場：依應用領域分類

  • 心血管外科
  • 一般外科
  • 整形外科
  • 整形和重組外科

第13章 外科手套市場：依最終用戶分類

  • 門診手術中心
    • 醫院相關
    • 獨立的
  • 診所
    • 門診部
    • 一般診所
  • 診斷中心
    • 診斷影像中心
    • 病理檢查室
  • 醫院
    • 私立醫院
    • 公立醫院

第14章 外科手套市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 外科手套市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 外科手套市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國外科手套市場

第18章 中國外科手套市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • Anhui Tianyuan Latex Technology Co.,Ltd.
  • Ansell Limited
  • Asma Rubber Products Pvt. Ltd.
  • B. Braun SE
  • Becton Dickinson and Company
  • Berner International GmbH
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Crown Healthcare Ltd.
  • Cypress Medical Products LLC
  • Dynarex Corporation
  • Harps Holdings Sdn. Bhd
  • Honeywell International Inc.
  • Kimberly-Clark Corporation
  • Kossan Rubber Industries Bhd.
  • Medisafe Technologies
  • Medline Industries, Inc.
  • Medtronic PLC
  • Motex Healthcare Corporation
  • Molnlycke Health Care AB
  • Sara Healthcare Pvt. Ltd.
  • SHOWA Group
  • Smart Glove Corporation Sdn Bhd.
  • Supermax Corporation Berhad
Product Code: MRR-02026C4C915C

The Surgical Gloves Market was valued at USD 2.60 billion in 2025 and is projected to grow to USD 2.75 billion in 2026, with a CAGR of 6.20%, reaching USD 3.96 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.60 billion
Estimated Year [2026] USD 2.75 billion
Forecast Year [2032] USD 3.96 billion
CAGR (%) 6.20%

The surgical gloves sector sits at the intersection of clinical safety, supply chain complexity, and evolving material science, making it a critical focal point for healthcare providers and procurement teams alike. In recent years, rising demand for higher-performance barrier protection, coupled with shifts in regulatory scrutiny and manufacturing geographies, has intensified stakeholder attention on quality, traceability, and cost efficiency. This analysis synthesizes current drivers shaping procurement decisions and operational risk, placing emphasis on how material selection, clinical application, and distribution choices collectively influence clinical outcomes and institutional budgets.

Across healthcare settings, procurement leaders must balance infection prevention imperatives with the practicalities of product comfort and clinician preference. At the same time, manufacturers face pressure to innovate on polymer formulations, reduce environmental footprint, and demonstrate consistent lot-to-lot quality. Consequently, transitions in sourcing strategies, validation protocols, and inventory management practices are increasingly central to institutional resilience. This introduction frames the subsequent sections by highlighting the strategic levers available to decision-makers seeking to optimize safety, supply continuity, and total cost of ownership without compromising clinical performance.

How material breakthroughs, regulatory tightening, evolving procurement channels, and changing clinical practice are collectively altering supplier and buyer strategies

The landscape for surgical gloves is undergoing transformative shifts driven by several converging forces that alter supplier dynamics, product portfolios, and clinical practice. First, material innovation has accelerated; alternative polymers and improved nitrile formulations have expanded options for tactile sensitivity and allergen mitigation, prompting clinicians and procurement teams to reassess prior preferences. Secondly, regulatory and quality expectations are tightening, with increased focus on sterility assurance, cytotoxicity profiles, and manufacturing traceability, which in turn elevates the value of suppliers who can demonstrate robust compliance systems.

Moreover, the distribution and procurement models are evolving as direct sales, distributor partnerships, and digital commerce compete to deliver cost transparency, speed, and customization. This shift is accompanied by an intensified emphasis on sustainability practices across production and packaging, influencing buyer selection criteria beyond unit price. Finally, clinical application patterns-such as growth in ambulatory procedures and specialization of surgical disciplines-are reshaping demand profiles. As a result, strategic winners will be those that align product innovation, regulatory robustness, and flexible go-to-market models to emerging healthcare delivery modalities.

Assessing the cumulative supply chain, sourcing, and procurement consequences of United States tariff policy adjustments affecting imports through 2025

Policy shifts affecting trade and tariffs in the United States through 2025 have imposed a new layer of complexity on the surgical gloves value chain, with cumulative effects reverberating from raw material sourcing to hospital procurement. Although official rates and specific classifications vary over time, the broader implications are consistent: increases in import costs incentivize reshoring conversations, alter supplier selection calculus, and prompt buyers to reassess inventory strategies to mitigate exposure to cross-border cost volatility. In turn, manufacturers and distributors are evaluating options such as contractual price adjustments, hedging procurement pipelines, and diversifying supplier footprints to preserve margin and availability.

In practical terms, healthcare institutions and buying groups are likely to encounter tighter negotiation cycles as suppliers pass through incremental cost pressures or seek longer-term agreements to stabilize volumes. Concurrently, there is an observable acceleration in investment toward domestic or nearshoring capacity among upstream producers, driven by the desire for supply assurance and reduced logistical complexity. Regulatory compliance and certification timelines can lengthen the path to market for new domestic entrants, yet the strategic appeal of reduced tariff exposure makes that transition a viable medium-term response. Ultimately, the cumulative tariff environment emphasizes the need for proactive scenario planning, supplier risk assessment, and collaborative contracting to ensure both fiscal discipline and clinical continuity.

Integrated segmentation analysis revealing how material choices, clinical settings, product type, powder preference, and distribution channels shape procurement decisions

Meaningful segmentation insights emerge when product attributes, end-user environments, and distribution models are considered together rather than in isolation. Material distinctions among latex, nitrile, polyisoprene, and vinyl drive different value propositions: latex still offers legacy performance characteristics in elasticity and fit for some clinicians, nitrile provides broad chemical resistance and reduced allergenicity, polyisoprene approaches latex-like feel without natural rubber proteins, and vinyl remains a cost-effective option for low-risk, short-duration tasks. These material attributes interact with clinical application needs, as surgical specialties such as cardiovascular surgery, general surgery, orthopedic surgery, and plastic and reconstructive surgery demand varying levels of tactile sensitivity, puncture resistance, and sterility assurance.

End-user segmentation further refines procurement strategies because ambulatory surgical centers, clinics, diagnostic centers, and hospitals exhibit distinct volume profiles, purchasing governance, and clinical workflows. Ambulatory surgical centers, whether hospital affiliated or independent, typically prioritize throughput and consistent procedure-specific kits, while clinics-outpatient clinics and polyclinics-focus on a broader set of low-to-medium acuity tasks where non-sterile options and powder-free preferences may predominate. Diagnostic centers such as imaging centers and pathology labs have unique glove requirements that emphasize contamination control and chemical resistance, and hospitals, both private and public, demand scalable sterile supplies aligned with surgical caseloads.

Type segmentation between non-sterile and sterile products directly affects supply chain security and inventory management, as sterile surgical gloves require validated sterilization and cold-chain considerations that extend lead times and qualification barriers. Powder considerations-powder free versus powdered-continue to influence clinician preference and regulatory acceptance, with powder-free options gaining favor where cross-sensitivity and wound contamination concerns are prioritized. Distribution channels of direct sales, distributors, and online retail shape accessibility and purchasing cadence; within online retail, both B2B platforms and B2C platforms are transforming procurement through digital catalogs, analytics-enabled replenishment, and faster comparison-shopping. When these segmentation layers are combined-material, end user, type, powder, distribution channel, and application-they create a multidimensional map that enables suppliers and buyers to target product development, optimize contract terms, and tailor inventory policies to clinical demand patterns.

Regional dynamics and sourcing realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, compliance, and supply reliability

Regional dynamics exert distinct influences on supply resilience, regulatory expectations, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, procurement strategies tend to emphasize consolidated vendor relationships with an eye toward logistical reliability and compliance with local regulatory frameworks, while buyers also evaluate nearshoring to mitigate transoceanic disruption. By contrast, Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement environment where certification harmonization and country-level public procurement rules materially affect supplier access and contracting models.

Asia-Pacific remains a critical production hub for polymer-based protective devices, with complex interdependencies between raw material feedstocks and finished goods manufacturing. As such, shifts in regional export policies, labor dynamics, and environmental compliance are particularly consequential for global supply chains. Across regions, stakeholders are adopting differentiated approaches: contingency sourcing and multi-supplier strategies in the Americas, stringent validation and clinical evidence emphasis in Europe, Middle East & Africa, and strategic supplier relationships and capacity audits in Asia-Pacific. Together, these regional vectors underline the importance of tailored commercial strategies that reflect local regulatory, logistical, and clinical realities while preserving global continuity of supply.

Competitive and strategic company behaviors including investment in sterile capacity, traceability, and service differentiation that determine long-term supplier selection

Competitive dynamics among manufacturers, contract suppliers, and distribution intermediaries are being reshaped by consolidation, vertical integration, and technology-enabled differentiation. Leading producers are investing in quality management systems, sterile manufacturing lines, and traceability technologies to meet heightened clinical and regulatory expectations, while contract manufacturers and private-label partners compete on agility and cost optimization. Distributors and direct-sales organizations are enhancing value propositions by offering integrated services such as sterilization validation support, product training programs for clinical staff, and data-driven inventory optimization tools that reduce stockouts and obsolescence risk.

New entrants and specialty firms focused on advanced polymer formulations and sustainability credentials are creating niche opportunities, particularly where clinical teams seek alternatives to traditional elastomers. Mergers and strategic partnerships are common as firms seek to secure upstream feedstocks or downstream distribution channels, enabling tighter control over lead times and quality. Overall, market participants that demonstrate robust regulatory compliance, operational resilience, and service-oriented commercial models are best positioned to capture long-term institutional relationships and to respond to shifting payer and provider priorities.

Actionable strategic priorities including diversified sourcing, clinical-focused innovation, and service-oriented commercial models to strengthen resilience and customer value

Industry leaders should pursue a set of coordinated actions that strengthen supply resilience, elevate product quality, and align commercial propositions with evolving clinical needs. First, invest in diversified sourcing strategies that combine regional production capacity, validated secondary suppliers, and inventory buffers to reduce exposure to trade-policy shifts and logistical disruptions. At the same time, accelerate adoption of materials and product profiles that address allergen concerns and deliver tactile performance suitable for high-acuity surgical specialties, while ensuring sterilization and quality systems meet tightening regulatory expectations.

Commercially, firms should expand value-added service offerings such as clinician education, sterile validation support, and analytics-enabled inventory management to deepen customer relationships and justify premium positioning. Collaboration between procurement teams and clinical leaders will be essential to implement standardized product formularies, streamline evaluation protocols, and realize predictable demand patterns. Finally, embed sustainability and lifecycle considerations into product development and packaging strategies to align with institutional ESG priorities, recognizing that environmental credentials increasingly factor into long-term supplier selection and contract renewal discussions.

Mixed-method research approach combining primary interviews, operational assessments, regulatory review, and scenario analysis to support actionable strategic insights

This research draws on a mixed-methods approach that integrates primary stakeholder interviews, operational audits, regulatory document review, and supply chain mapping to create a comprehensive view of contemporary dynamics. Primary interviews included procurement leads, clinical end users, manufacturing operations managers, and distribution partners, yielding qualitative insights into preference drivers, risk tolerance, and contractual behaviors. Complementing these interviews, operational audits and manufacturing assessments provided objective measures of production capabilities, sterilization workflows, and quality management system robustness.

Regulatory and standards documentation was reviewed to align product attributes with prevailing certification expectations, while trade and logistics analyses illuminated potential disruption points across sourcing routes. Where appropriate, scenario analysis was applied to stress-test sourcing options against tariff volatility and capacity constraints, enabling pragmatic recommendations. Throughout the research process, data integrity was maintained through triangulation across multiple sources and cross-validation with industry practitioners to ensure that findings reflect operational realities and actionable implications for commercial and clinical stakeholders.

Synthesis of strategic imperatives highlighting how integrated sourcing, quality assurance, and clinical collaboration drive resilience and competitive advantage

In conclusion, the surgical gloves landscape is being reconstituted by material innovation, regulatory refinement, shifting distribution paradigms, and policy-driven supply chain pressures. These factors collectively compel manufacturers, distributors, and healthcare purchasers to adopt more sophisticated sourcing, product differentiation, and service strategies. Organizations that proactively invest in diversified supply footprints, sterile manufacturing capability, and clinician-focused product development will be better positioned to navigate tariff-related cost pressures and evolving clinical requirements.

As providers prioritize both safety and operational efficiency, the suppliers that can demonstrate validated quality systems, traceability, and contextualized commercial solutions will win durable partnerships. The path forward requires integrated planning across procurement, clinical governance, and supplier management to translate intelligence into resilient contracts and clinical continuity. Stakeholders who act decisively to align capabilities with emerging demand patterns and regulatory expectations will secure both clinical trust and commercial advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Gloves Market, by Type

  • 8.1. Non Sterile
  • 8.2. Sterile

9. Surgical Gloves Market, by Material

  • 9.1. Latex
  • 9.2. Nitrile
  • 9.3. Polyisoprene
  • 9.4. Vinyl

10. Surgical Gloves Market, by Powder

  • 10.1. Powder Free
  • 10.2. Powdered

11. Surgical Gloves Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Retail
    • 11.3.1. B2B Platforms
    • 11.3.2. B2C Platforms

12. Surgical Gloves Market, by Application

  • 12.1. Cardiovascular Surgery
  • 12.2. General Surgery
  • 12.3. Orthopedic Surgery
  • 12.4. Plastic & Reconstructive Surgery

13. Surgical Gloves Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital Affiliated
    • 13.1.2. Independent
  • 13.2. Clinics
    • 13.2.1. Outpatient Clinics
    • 13.2.2. Polyclinics
  • 13.3. Diagnostic Centers
    • 13.3.1. Imaging Centers
    • 13.3.2. Pathology Labs
  • 13.4. Hospitals
    • 13.4.1. Private Hospitals
    • 13.4.2. Public Hospitals

14. Surgical Gloves Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Surgical Gloves Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Surgical Gloves Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Surgical Gloves Market

18. China Surgical Gloves Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Abbott Laboratories
  • 19.7. Anhui Tianyuan Latex Technology Co.,Ltd.
  • 19.8. Ansell Limited
  • 19.9. Asma Rubber Products Pvt. Ltd.
  • 19.10. B. Braun SE
  • 19.11. Becton Dickinson and Company
  • 19.12. Berner International GmbH
  • 19.13. Boston Scientific Corporation
  • 19.14. Cardinal Health Inc.
  • 19.15. Crown Healthcare Ltd.
  • 19.16. Cypress Medical Products LLC
  • 19.17. Dynarex Corporation
  • 19.18. Harps Holdings Sdn. Bhd
  • 19.19. Honeywell International Inc.
  • 19.20. Kimberly-Clark Corporation
  • 19.21. Kossan Rubber Industries Bhd.
  • 19.22. Medisafe Technologies
  • 19.23. Medline Industries, Inc.
  • 19.24. Medtronic PLC
  • 19.25. Motex Healthcare Corporation
  • 19.26. Molnlycke Health Care AB
  • 19.27. Sara Healthcare Pvt. Ltd.
  • 19.28. SHOWA Group
  • 19.29. Smart Glove Corporation Sdn Bhd.
  • 19.30. Supermax Corporation Berhad

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GLOVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL GLOVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GLOVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL GLOVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GCC SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. GCC SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. GCC SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 216. GCC SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. GCC SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 249. G7 SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 252. G7 SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. NATO SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. NATO SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. NATO SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. NATO SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. NATO SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)